Any feedback?
Literature summary for 4.1.1.2 extracted from
- 14-day repeat-dose oral toxicity evaluation of oxazyme in rats and dogs (2010), Int. J. Toxicol., 29, 20-31.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Bacillus subtilis | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| oxalate + H+ | - |
Bacillus subtilis | CO2 + formate | - |
? |  |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| oxazyme | oxazyme (OC4) is an orally administered formulation that has as an active component a recombinant mutant form of Bacillus subtilis oxalate decarboxylase (OxDC) enzyme C383S | Bacillus subtilis |
| OXDC | - |
Bacillus subtilis |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
